In February 2011, Synosia Therapeutics was acquired by Biotie, a specialized drug development company focused on the development of drugs for neurodegenerative and psychiatric disorders, such as Parkinson’s and Alzheimer’s disease, and inflammatory diseases, including rheumatoid arthritis.

For more information, visit www.biotie.com

hands purple